You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 10, May 28, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (110)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Substance Abuse/ Alcoholism
 •HIV/AIDS
 •Sexually Transmitted Diseases
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic

Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug Users

A 10-Year Perspective

Steffanie A. Strathdee, PhD; Noya Galai, PhD; Mahboobeh Safaiean, MPH; David D. Celentano, ScD; David Vlahov, PhD; Lisette Johnson, MA; Kenrad E. Nelson, MD

Arch Intern Med. 2001;161:1281-1288.

Background  Injection drug use directly or indirectly accounts for nearly half the annual human immunodeficiency virus (HIV) infections in the United States. Prospective studies that investigate both sexual and parenteral HIV risks among injection drug users (IDUs) are needed. We studied factors for HIV seroconversion among male and female IDUs in Baltimore, Md.

Methods  The HIV-negative IDUs (1447 male and 427 female) were recruited into a prospective study from 1988 to 1989 or in 1994. Participants underwent semiannual HIV tests and surveys through December 1998. Poisson regression was used to identify risk factors for HIV seroconversion, stratified by sex. Behaviors were treated as time-dependent covariates that varied at each semiannual period.

Results  Subjects were primarily African American (91%), and median age at enrollment was 35 years. Incidence of HIV was 3.14 per 100 person years (95% confidence interval, 2.78-3.53) and did not significantly differ by sex. Younger age independently predicted HIV seroconversion for both men and women. Among men, factors that independently predicted HIV seroconversion were the following: less than a high school education, recent needle sharing with multiple partners, daily injection, and shooting-gallery attendance. The incidence of HIV was double for men recently engaging in homosexual activity and cocaine injection. Among women, the incidence of HIV was more than double for those recently reporting sexually transmitted diseases.

Conclusions  The incidence of HIV remained high among IDUs in Baltimore over the past decade. Risk factors for HIV seroconversion differed markedly by sex. Predominant risks among men included needle sharing and homosexual activity; among women, factors consistent with high-risk heterosexual activity were more significant than drug-related risks. Human immunodeficiency virus interventions aimed at IDUs should be sex-specific and incorporate sexual risks.


From the Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Md (Drs Strathdee, Celentano, Vlahov, and Nelson, and Mss Safaiean Johnson); Ben-Gurion University, Beer Sheeva, Israel (Dr Galai); and the Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, New York (Dr Vlahov).


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2001;161(10):1355-1356.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets
Kivela et al.
Eur J Public Health 2007;17:381-386.
ABSTRACT | FULL TEXT  

Rate of methadone use among Aboriginal opioid injection drug users
Wood et al.
CMAJ 2007;177:37-40.
ABSTRACT | FULL TEXT  

Maintenance of endemicity in urban environments: a hypothesis linking risk, network structure and geography
Rothenberg
Sex. Transm. Infect. 2007;83:10-15.
ABSTRACT | FULL TEXT  

Preclinical Development and Clinical Implementation of Treatments for Substance Abuse Disorders
Pechnick et al.
Focus 2007;5:151-162.
ABSTRACT | FULL TEXT  

Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
Wood et al.
CMAJ 2006;175:1399-1404.
ABSTRACT | FULL TEXT  

Marital status and longevity in the United States population.
Kaplan and Kronick
J. Epidemiol. Community Health 2006;60:760-765.
ABSTRACT | FULL TEXT  

HEPATITIS C INFECTION AMONG DRUG USERS IN NORTHERN THAILAND
JITTIWUTIKARN et al.
Am J Trop Med Hyg 2006;74:1111-1116.
ABSTRACT | FULL TEXT  

Service Uptake and Characteristics of Injection Drug Users Utilizing North America's First Medically Supervised Safer Injecting Facility
Wood et al.
Am. J. Public Health 2006;96:770-773.
ABSTRACT | FULL TEXT  

Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users
Wood et al.
Int J Epidemiol 2005;34:152-158.
ABSTRACT | FULL TEXT  

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users
Wood et al.
CMAJ 2004;171:731-734.
ABSTRACT | FULL TEXT  

HIV Seroprevalence Among Homeless and Marginally Housed Adults in San Francisco
Robertson et al.
Am. J. Public Health 2004;94:1207-1217.
ABSTRACT | FULL TEXT  

Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT | FULL TEXT  

HIV-1 in genital tract and plasma of women: Compartmentalization of viral sequences, coreceptor usage, and glycosylation
Kemal et al.
Proc. Natl. Acad. Sci. USA 2003;100:12972-12977.
ABSTRACT | FULL TEXT  

Trends in Human Immunodeficiency Virus Seroincidence among Street-Recruited Injection Drug Users in San Francisco, 1987-1998
Kral et al.
Am J Epidemiol 2003;157:915-922.
ABSTRACT | FULL TEXT  

Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure
Wood et al.
CMAJ 2003;168:165-169.
ABSTRACT | FULL TEXT  

Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver
Craib et al.
CMAJ 2003;168:19-24.
ABSTRACT | FULL TEXT  

Understanding the Implications of HIV Disease in Women
Carney
The Family Journal 2003;11:84-88.
ABSTRACT  

Temporal Trends in the Incidence of Human Immunodeficiency Virus Infection and Risk Behavior among Injection Drug Users in Baltimore, Maryland, 1988-1998
Nelson et al.
Am J Epidemiol 2002;156:641-653.
ABSTRACT | FULL TEXT  

HIV and AIDS Risk Behaviors Among Female Jail Detainees: Implications for Public Health Policy
McClelland et al.
Am. J. Public Health 2002;92:818-825.
ABSTRACT | FULL TEXT  

Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver
Spittal et al.
CMAJ 2002;166:894-899.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.